UP!
Corindus Vascular Robotics (Corindus, Inc.) was founded in 2002 by Rafael Beyar, an interventional cardiologist, and Tal Wenderow. Its goal is to use remote control and robotics to move coronary guidewires and balloon/stent catheters.
Corindus, Inc. is based in Waltham, Massachusetts. The company’s FDA-cleared CorPath® System is the first medical device that allows interventional cardiologists to manipulate guidewires and balloon/stents from an interventional cockpit.
The company went public in August 2014 and currently trades on the New York Stock Exchange with the ticker symbol CVRS.
| 2016-04-20 | Reiterated Rating | Sterne Agee CRT | Buy | $3.00 |
| 2016-01-19 | Lower Price Target | Stifel Nicolaus | Buy | $6.00 to $4.00 |
| 2015-06-23 | Initiated Coverage | Cowen and Company | Outperform | $5.25 |
| 2015-06-23 | Initiated Coverage | Stifel Nicolaus | Buy | $6.00 |
| 2016-04-20 | Reiterated Rating | Sterne Agee CRT | Buy | $3.00 |
| 2016-01-19 | Lower Price Target | Stifel Nicolaus | Buy | $6.00 to $4.00 |
| 2015-06-23 | Initiated Coverage | Cowen and Company | Outperform | $5.25 |
| 2015-06-23 | Initiated Coverage | Stifel Nicolaus | Buy | $6.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CVRS 5 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 1.66M |
| BlackRock Institutional Trust Company, N.A. | 0.36M |
| BlackRock Investment Management, LLC | 0.18M |
| MENTA CAPITAL LLC | 80311 |
| BLACKROCK ADVISORS LLC | 34998 |
UM